公司問答丨湯臣倍健:BYHEALTH目前收入貢獻主要來自中國跨境電商渠道
格隆匯6月10日丨有投資者在互動平台向湯臣倍健公司提問:我最近在用海外版的醒肝片,覺得這個產品效果比國內的好很多,但是直播間人氣一直很低。公司有沒有考慮過將線上和線下銷售分開,用海外版的新品牌的形式進行線上銷售呢?把醒肝片這些產品整合到lifespace一起直播,利用l的人氣,將更多的產品帶給客户。用現有的湯臣倍健做基礎,海外產品做增長級。湯臣倍健迴應:BYHEALTH品牌定位湯臣倍健海外版,通過創新劑型、原料和配方等打造差異化的高能營養產品,目前收入貢獻主要來自中國跨境電商渠道。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.